Twist Bioscience Corporation (BIT:1TWST)

Market Cap	2.93B +35.1%
Revenue (ttm)	333.49M +18.6%
Net Income	-65.23M
EPS	-1.08
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	250
Average Volume	40
Open	49.98
Previous Close	48.26
Day's Range	48.57 - 49.98
52-Week Range	19.50 - 50.88
Beta	n/a
RSI	64.05
Earnings Date	May 4, 2026

About Twist Bioscience

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and ...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2013
• Employees: 979
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1TWST

Financial Performance

In fiscal year 2025, Twist Bioscience's revenue was $376.57 million, an increase of 20.32% compared to the previous year's $312.97 million. Losses were -$77.67 million, -62.79% less than in 2024.

Financial numbers in USD